• Cardiovascular Disorders - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PNS72 Charting the Progress of HTA in Asia: Are We Ready for Evidence Based Decision-Making?

    Jun 1, 2021, 00:00

  • PGI24 Complications and Healthcare Utilization in Adult Patients Receiving Parenteral Support for Intestinal Failure Associated with Short Bowel Syndrome

    Jun 1, 2021, 00:00

  • PRO22 Hospital Length of Stay, Total Costs and Comorbidities in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Analysis of National In-patient Hospital Database

    Jun 1, 2021, 00:00

  • PRO41 The Economic and Quality of Life impact of Entrectinib on CNS metastasis control

    Jun 1, 2021, 00:00

  • PCN44 Cost-Effectiveness of Durvalumab Following Chemoradiotherapy in Unresectable Stage III NSCLC Patients in the US: An Update Based on 4-Year Survival Data

    Jun 1, 2021, 00:00

  • PDB40 Eliciting Patient Preferences for Continuous Glucose Monitoring Devices in Type 1 Diabetes

    Jun 1, 2021, 00:00

  • PMU16 Hospital Outcomes Attributable to Congestive Heart Failure in Patients with Endometrial Cancer in the U.S.: A Retrospective Analysis

    Jun 1, 2021, 00:00

  • PCN78 A Set of Systematic and Targeted Reviews to Identify the Burden of Iron Chelation Therapy in Myelodysplastic Syndromes

    Jun 1, 2021, 00:00

  • PMU54 A Claims-Based Algorithm to Identify Inadequate Response to Immunomodulatory Therapies Among Patients with Selected Autoimmune Diseases

    Jun 1, 2021, 00:00

  • PIN46 COVID-19 Patients Analysis Utilizing JAPAN and US Claims Databases

    Jun 1, 2021, 00:00

  • PSU16 Trends in the Adoption of Different Surgical Approaches across Specialties: A National Study from 2013 to 2019

    Jun 1, 2021, 00:00

  • PRO25 Trend in Hospital Length of Stay, Costs and Comorbidities in Patients with Veno-Occlusive Disease (VOD): Analysis of National in-Patient Hospital Database

    Jun 1, 2021, 00:00

  • CO3 Comparison of Goal Attainment and Measures of Function in Two Dementia Clinical Trials.

    Jun 1, 2021, 00:00

  • PMS12 Healthcare Costs and Insurance Coverage of Rheumatoid Arthritis Patients in the United States: A 2018 Medical Expenditure Panel Survey Data Analysis

    Jun 1, 2021, 00:00

  • Gastrointestinal Disorders - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PMH22 The Use of Naloxone in Opioid Overdose and Overdose at-Risk Populations: A Retrospective Medical Claims Analysis

    Jun 1, 2021, 00:00

  • PRO10 Indirect Treatment Comparison of Myalepta (Metreleptin) Compared to Best Supportive Care in Lipodystrophy

    Jun 1, 2021, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PRO78 Real-World Treatment Patterns in Patients with Light Chain (AL) Amyloidosis: Analysis of the Optum US Electronic Health Records (EHR) and Commercial Claims Database

    Jun 1, 2021, 00:00

  • PCN161 Continuity of Care, Health Resource Utilization, Cost and Mortality in Medicare Prostate Cancer Patients

    Jun 1, 2021, 00:00

  • PMD16 What Factors Do Clinicians Value Most in Selecting Physician Preference Items? a Survey in Orthopedics Using Discrete Choice Experiment and Best-Worst Scaling

    Jun 1, 2021, 00:00

  • PND49 An Assessment of Real-World Healthcare Provider Experiences with Insomnia Medications Focusing on Suvorexant in the United States (US)

    Jun 1, 2021, 00:00

  • PR3 Identifying Preferences for Closed-Loop Insulin Systems Among Children with Type 1 Diabetes and Their Parents: A Discrete Choice Experiment

    Jun 1, 2021, 00:00

  • PIN71 Influencing Factors and Economic Burden of Carbapenem Resistant Klebsiella Pneumoniae Pulmonary Infection in Neurosurgical Patients

    Jun 1, 2021, 00:00

  • PMU21 Factors Related to the Consumption of Antibiotics, a MIXED Methodology Study from the Post Conflicted Areas of SWAT Khyber-Pakhtunkhwa, Pakistan.

    Jun 1, 2021, 00:00

  • Systemic Disorders/Conditions - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • PDB35 Trajectory of Glycated Hemoglobin Over Time Among Obese Type 2 Diabetes Patients Prescribed U-100 Basal-only Insulin Regimens: A US Administrative Claims Data Analysis

    Jun 1, 2021, 00:00

  • PCN38 A Literature Review Of Recurrent Or Metastatic Cervical Cancer Disease Burden, Treatment Outcomes, And Unmet Needs

    Jun 1, 2021, 00:00

  • PNS26 Explaining Cognitive Impairment Among Adults with Chronic Pain: Non-Linear Decomposition Analysis of 2015 MEPS Data

    Jun 1, 2021, 00:00

  • PRO27 Budget IMPACT Analysis of Pegvisomant in the Treatment Acromegaly in Colombia

    Jun 1, 2021, 00:00

  • CO4 Predictors of Inpatient Relapse in Multiple Sclerosis Patients Using First-Line Disease Modifying Therapies: A Machine Learning Study of Real World Data

    Jun 1, 2021, 00:00

  • PMS10 Trends in Leaves Due to Long- and Short-Term Disability and Workers' Compensation for Employees with Back Pain in the United States

    Jun 1, 2021, 00:00

  • PCN212 Age Disparities in Initial Surgery in Patients with Gliomas: A SEER Analysis

    Jun 1, 2021, 00:00

  • PCN134 Assessing the Relationship between Immature and Mature Overall Survival (OS) Outcomes on HTA Decision-Making: A Study of UK Nice Decisions and the Case for Coverage with Evidence Development

    Jun 1, 2021, 00:00

  • PRS10 Economic Evaluation of Umeclidinium/Vilanterol Versus Umeclidinium or Salmeterol in a UK COPD Population at Low Risk of Exacerbations Using the GALAXY Model

    Jun 1, 2021, 00:00

  • PCN79 Healthcare Resource Utilization (HRU) of Immune Checkpoint Inhibitors in Metastatic LUNG Cancer Patients

    Jun 1, 2021, 00:00

  • PNS25 Changing in Health Care Service Demand during the COVID-19 Pandemic in 2020: A Study Case of a Subsidized Health Care Company in the Caribbean Region of Colombia

    Jun 1, 2021, 00:00

  • PMU43 VALUE-Based Pricing in Colombia: The Devil Is in the Details

    Jun 1, 2021, 00:00

  • Medical Devices - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PMU49 Patient Heterogeneity and the Limitations of One-Size-Fits-All Value-Based Pricing: A Systematic Review and Future Directions

    Jun 1, 2021, 00:00

  • Expediting Patient Access to New Health Technologies: Role of Disease-Specific Reference Models

    Jun 1, 2021, 00:00

  • PND19 Healthcare Burden of Medication-Overuse Headache in Patients with Migraine

    Jun 1, 2021, 00:00

  • Health Technology Assessment Studies

    Jun 1, 2021, 00:00

  • PNS61 The Second Coming of the Nice Appeal Process?

    Jun 1, 2021, 00:00

  • Surgery - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PIN56 Content Analysis of FDA Warning Letters for Fraudulent COVID-19 Claims Using the Economic, Clinical, Humanistic Outcomes (ECHO) MODEL

    Jun 1, 2021, 00:00

  • PNS108 Psychometric Validation of New Scales Expanding Conceptual Coverage of the ABOUTTM-Perceived Risk: Perceived Social Risk and Perceived Practical Risk

    Jun 1, 2021, 00:00

  • Rare Public Health

    Jun 1, 2021, 00:00

  • PIH9 Cost-Effectiveness of Myomectomy VS. Hysterectomy in Women with Uterine Fibriods

    Jun 1, 2021, 00:00

  • PND41 Direct Medical Costs of Parkinson's Disease in JAPAN

    Jun 1, 2021, 00:00

  • PRO54 Humanistic Burden of Chronic Hypoparathyroidism - Results of a Systematic Literature Review

    Jun 1, 2021, 00:00

  • Infectious Diseases - Patient-Centered Research

    Jun 1, 2021, 00:00

  • Patient Behavior Studies

    Jun 1, 2021, 00:00

  • PMU60 Assessing the Readability of Patient-Reported Outcome Measures in Trials for Drugs with Recent FDA Approval

    Jun 1, 2021, 00:00

  • Urinary/Kidney Disorders - Patient-Centered Research

    Jun 1, 2021, 00:00

  • ST3 Development of a Survey-Based Predictive Model for Clinical Dementia Rating in Alzheimer's Disease

    Jun 1, 2021, 00:00

  • PMU26 Changes in Schedule II Opioid Prescriptions Dispensed By Medicaid in Following ACUTE PAIN Opioid Restriction LAWS

    Jun 1, 2021, 00:00

  • PDG13 Healthcare Expenditures and Resource Utilization Among a Nationally Representative Population of Narcotic Users in the United States, 2008 to 2017

    Jun 1, 2021, 00:00

  • PCN37 An Oncology Real-World Data Assessment Framework for Outcomes Research

    Jun 1, 2021, 00:00

  • Systemic Disorders/Conditions - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PR4 Health Utility Assessment of Different Options for Treatment of Iron Deficiency Anemia: Results from Time-Trade-Off Study in China

    Jun 1, 2021, 00:00

  • AI2 The Impact of Including Race and Ethnicity in Risk Prediction Models on Racial Bias

    Jun 1, 2021, 00:00

  • PMH14 Association between Substance Use Disorder and Mental Health Service Utilization Among Adults with Major Depressive Disorder Using the National Survey on Drug Use and Health

    Jun 1, 2021, 00:00

  • PIT5 Cost Savings of Autologous Cell Harvesting Device for the Treatment of Burns Requiring Hospitalization: An Economic Evaluation Using Real-World DATA

    Jun 1, 2021, 00:00

  • PCV24 A Threshold Analysis of the Cost-Effectiveness of Adjunctive Inclisiran Therapy for Ascvd Patients with LDL ≥70 MG/DL on Maximally Tolerated Statin Therapy

    Jun 1, 2021, 00:00

  • PMH47 Medication Use Patterns Among Adult Mhealth Users with ADHD

    Jun 1, 2021, 00:00

  • PIN81 Towards a Better Understanding of COVID-19 Among Young Adults Ages 18-24

    Jun 1, 2021, 00:00

  • PMU71 Real World Data Availability in Latin America: Assessment and Implications for Research and Healthcare Decision Making

    Jun 1, 2021, 00:00

  • Respiratory-Related Disorders - Health Policy Regulatory

    Jun 1, 2021, 00:00

  • PDB15 Cost-Effectiveness of a NOVEL Treatment for Diabetic Foot Ulcer Among Patients with Diabetes: A Modeling Study

    Jun 1, 2021, 00:00

  • PMD6 Procedure Cost-Comparison Analysis of Liquid Embolic System Techniques Using EVOH and n-BCA in the Embolization of Brain Arteriovenous Malformations

    Jun 1, 2021, 00:00

  • ML4 Association of Incident Cancer with Low-Value Care among Elderly Medicare Beneficiaries Using Machine Learning

    Jun 1, 2021, 00:00

  • PMU28 Association between Social Determinants of Health and Depression Among Patients with Psoriasis in the US

    Jun 1, 2021, 00:00

  • Gastrointestinal Disorders - Economic Evaluation

    Jun 1, 2021, 00:00

  • Award Winners

    Jun 1, 2021, 00:00

  • PNS46 Development of Consumer-Reported Outcome Measure (CROM) Standards for the Tobacco Industry with Respect to Psychometric CROM Using a Consortium-Based Approach: Methodology and Scope

    Jun 1, 2021, 00:00

  • Respiratory-Related Disorders - Health Technology Assessment

    Jun 1, 2021, 00:00

  • PNS33 Recommendations for the Design and Implementation of an Early Feasibility Studies Program in Italy

    Jun 1, 2021, 00:00

  • PNS106 Quality of Life Evaluation in the UK General Population Using the Pedsql Questionnaire

    Jun 1, 2021, 00:00

  • PUK2 Hospitalization in Patients Receiving Maintenance Dialysis with Hyperphosphatemia Randomized to Tenapanor or Sevelamer

    Jun 1, 2021, 00:00

  • PCV18 Implementation of Pharmacogenomic Clinical Decision Support Alerts in Learning Health Systems: A Cost-Utility Analysis

    Jun 1, 2021, 00:00

  • PND14 Expanding the Components of Economic Analyses of Pharmacotherapy for Parkinson's Disease

    Jun 1, 2021, 00:00

  • PCV12 The Economic Burden of out-of-Hospital Cardiac Arrest Increases with Severity of Prognosis Among US Medicare Older Adults (2017-2019)

    Jun 1, 2021, 00:00

  • PNS115 Real World Evidence to Support Regulatory Decisions: Frameworks for Latin American Agencies

    Jun 1, 2021, 00:00

  • Multiple Diseases - Health Policy Regulatory

    Jun 1, 2021, 00:00

  • PCN160 Potential Impact of Advanced Therapy Medicinal Products on Irish Hematology-Oncology Care Pathway

    Jun 1, 2021, 00:00

  • PCN31 Matching Adjusted Indirect Treatment Comparison of FGFR2+ Patients in the FIGHT-202 Trial vs. Patients with Unspecified FGFR2 Status Receiving Standard of Care Treatments

    Jun 1, 2021, 00:00

  • PCV20 Cost-Effectiveness of a Tacrolimus-Mycophenolate Mofetil Regimen for Organ Rejection Prophylaxis in Heart Transplant Recipients in Colombia

    Jun 1, 2021, 00:00

  • PDB34 Comparative Efficacy and Safety of Avatrombopag Versus Lusutrombopag in Patients with Chronic LIVER Disease and Severe Thrombocytopenia Undergoing Invasive Procedures: A Systematic Literature Review and Network Meta-Analysis

    Jun 1, 2021, 00:00

  • PGI13 Economic Burden Associated with Strictures and/or Fistulae Among Commercially Insured Patients Diagnosed with Crohn?s Disease in the US

    Jun 1, 2021, 00:00

  • PMH42 Early Improvements in Functioning and Quality of Life with AXS-05 in Major Depressive Disorder: Resultsfrom the GEMINI Trial

    Jun 1, 2021, 00:00

  • PRO53 Symptoms and impact of aromatic l-amino acid decarboxylase deficiency (AADCd): A qualitative study

    Jun 1, 2021, 00:00

  • PIH24 Medical Home Implementation Reduced Inappropriate Medication Use Among Older Adults in Parma, Italy: Does Early Adoption and Duration of Experience Matter?

    Jun 1, 2021, 00:00

  • No Specific Disease - Medical Technologies

    Jun 1, 2021, 00:00

  • PND50 Patterns of Home Health Care Use and Associated Costs in Elderly with Alzheimer's Disease and Related Dementias

    Jun 1, 2021, 00:00

  • PCN214 Responsiveness and Responder Definitions for the NCCN/FACT Bladder Symptom Index (NFBISI-18) in Individuals With Locally Advanced or Metastatic Urothelial Cancer (UC)

    Jun 1, 2021, 00:00

  • Mental Health - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PNS30 The Humanistic and Economic Costs of Conversion Therapy: A Systematic Literature Review

    Jun 1, 2021, 00:00

  • PBI9 The TOTAL Medical Expenditure and out-of-Pocket Expenditure of Biologic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis Patients in the United States

    Jun 1, 2021, 00:00

  • PCN183 A Cost-Effectiveness Analysis of Nivolumab plus Ipilimumab plus Two Cycles of Platinum Doublet-Chemotherapy Versus Platinum Doublet Chemotherapy in the First-Line Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer in Canad ...

    Jun 1, 2021, 00:00

  • PRO58 Beyond Color Blindness: The Patient and Societal IMPACT of Photoaversion and Vision Loss Associated with Achromatopsia

    Jun 1, 2021, 00:00

  • PCN86 A Retrospective Observational Analysis of the Healthcare Economic Burden of Patients NEWLY Diagnosed with Hepatocellular Carcinoma and Treated with Locoregional Therapies in the United States

    Jun 1, 2021, 00:00

  • PBI20 Physician Reported Reasons for Advanced Therapy Treatment Switches in Rheumatoid Arthritis Patients: Results From a Cross-Sectional Survey in the USA

    Jun 1, 2021, 00:00

  • PGI9 Using a New Powered Stapling System with Gripping Surface Technology Is Associated with Better Intraoperative Outcomes Among Patients with Gastric Carcinoma

    Jun 1, 2021, 00:00

  • Personalized Precision Medicine - Patient-Centered Research

    Jun 1, 2021, 00:00

  • CN2 Eliciting Unreported Subgroup-Specific Survival from Aggregate Randomized Controlled Trial Data

    Jun 1, 2021, 00:00

  • PCN152 Prescribed Opioid Doses in Cancer Survivors Pre- and Post-Curative Intent Radiation

    Jun 1, 2021, 00:00

  • PNS48 Do US Commercial Health Plans Cite ICER Reports in Their Specialty Drug Coverage Policies? an Empirical Analysis

    Jun 1, 2021, 00:00

  • PND59 Determining the Relationship of Seizures, Seizure-Free Days (SFDS) and Other Predictors of Health-Related Quality of Life (HRQOL) in Patients with Dravet Syndrome (DS) and Their Carers

    Jun 1, 2021, 00:00

  • PIN17 Pharmacoeconomic Analysis of Antiretroviral Therapy (ART) Based on Local D?ta from Real Clinical Practice, and Modeling Changes in Approaches to the HIV Treatment in the Russian Federation

    Jun 1, 2021, 00:00

  • PCN93 Cost-Utility Analysis Of BRAF Mutation Testing For Election Of Adjuvant Treatment Of Melanoma In Colombia

    Jun 1, 2021, 00:00

  • PDB14 Obesity and Their Comorbidities in Chile: An Open Database Analysis to Solve Local Gaps in Clinical Inputs for Economic Evaluations.

    Jun 1, 2021, 00:00

  • PND44 Patient Characteristics and Comorbidities in Patients with Essential Tremor: A Retrospective Observational Study in a United States Commercially Insured and Medicare Advantage Population

    Jun 1, 2021, 00:00

  • PBI3 Comparative Efficacy of Bimekizumab for the Treatment of Moderate to Severe Plaque Psoriasis: A Network Meta-Analysis

    Jun 1, 2021, 00:00

  • PMS9 A Retrospective Cohort Analysis of the Impact of Osteoarthritis on Disability Leave, Worker's Compensation Claims, and Healthcare Payments

    Jun 1, 2021, 00:00

  • PCN92 Temporal Trends in Grade 3/4 Adverse Events and Associated Costs of Nivolumab Plus Cabozantinib (N+C) Versus Sunitinib (S) for Previously Untreated Advanced Renal Cell Carcinoma (aRCC)

    Jun 1, 2021, 00:00

  • PMD18 Reduction in Pedicle SCREW Placement Time with a Guidewireless Pedicle SCREW System for Minimally Invasive SPINE Surgery

    Jun 1, 2021, 00:00

  • PMU37 Influence of Patient Population NON-Oncology Biopharmaceutical Innovations.

    Jun 1, 2021, 00:00

  • PCN9 A Real-World Assessment of the Treatment Patterns, Health Resource Utilization and Outcomes Associated with Esophageal Cancer in the United States

    Jun 1, 2021, 00:00

  • SM4 The New SMC Ultra-Orphan Pathway: HTA Best Practice for Very Rare Diseases?

    Jun 1, 2021, 00:00

  • PCV6 The Use of Ibuprofen, Including Versus Indomethacin or Paracetamol/Acetaminophen, for the Closure of Patent Ductus Arteriosus in Preterm Infants. a Systematic Review of Meta-Analyses

    Jun 1, 2021, 00:00

  • PCN163 Acute Healthcare Utilization and Costs After Initiating First-line Targeted Therapy for Metastatic Lung Cancer in the US

    Jun 1, 2021, 00:00

  • HT2 Evaluation of Tucatinib for HER2-Positive Breast Cancer Patients with Brain Metastases: A United States-Based Cost-Effectiveness Analysis

    Jun 1, 2021, 00:00

  • PNS18 Equal Value of Life-Years Gained: Comparison of Methodologies for a Cohort Markov Model

    Jun 1, 2021, 00:00

  • PCN47 Value of Driver Mutation Testing Strategies based on Next-Generation Sequencing (NGS) for Patients with Metastatic Non-Small Cell Lung Cancer (mNSCLC)

    Jun 1, 2021, 00:00

  • PND67 Factors Associated with Prescribing of Disease-Modifying Agents Among Older Adults with Multiple Sclerosis: A Real-World Analysis of Electronic Medical Records

    Jun 1, 2021, 00:00

  • Surgery - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PCN42 Budget Impact Analysis of the Oncotype DX Breast Cancer Recurrence Score Test to Guide Chemotherapy Use in ER+/HER2- Node-Negative Early Invasive Breast Cancer

    Jun 1, 2021, 00:00

  • PMU44 Quality of Life and Costs of a Telemedicine Service for Ophthalmologic Diagnoses

    Jun 1, 2021, 00:00

  • Individual's Health - Economic Evaluation

    Jun 1, 2021, 00:00

  • Musculoskeletal Disorders - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • PCV35 Costs of Septal Reduction Therapy for Obstructive Hypertrophic Cardiomyopathy: A US Claims Analysis

    Jun 1, 2021, 00:00

  • PGI14 Budget IMPACT Analysis of Tofacitinib in the Treatment of Ulcerative Colitis in the Perspective of Brazilian Public Healthcare System

    Jun 1, 2021, 00:00

  • PSU7 Cost-Effectiveness of PRE-Operative Spinal Imaging for Suspected Stiff or Hypermobile SPINE before TOTAL HIP Arthroplasty

    Jun 1, 2021, 00:00

  • PMU42 Inclusion of Background Variables of the Theory of Planned Behavior to Predict Provider Intention to Prescribe Buprenorphine

    Jun 1, 2021, 00:00

  • PCV5 Risk Factors Associated with Recurrence and Corticosteroid-Associated Adverse Events in Patients with Recurrent Pericarditis

    Jun 1, 2021, 00:00

  • Drugs Generics - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PCN242 Treatment Patterns, Clinical Outcomes, And Healthcare Resource Use Among Patients With Stage IV Urothelial Cancer: Findings From A Nationwide Cohort Study In Denmark

    Jun 1, 2021, 00:00

  • Cardiovascular Disorders - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • PRS20 Diagnosed Prevalence, Patient Characteristics, and Treatment Among Adult Patients with Chronic Rhinosinusitis with Nasal Polyps in Maccabi Health Services

    Jun 1, 2021, 00:00

  • PIN51 Role of Asymptomatic Carriers in the Transmission of COVID-19: A Review

    Jun 1, 2021, 00:00

  • PCN218 Burden of Illness on Patients And Caregivers and Quality of Life Outcomes of Triple-Class Exposed (TCE) Patients With Multiple Myeloma (MM) In The United States

    Jun 1, 2021, 00:00

  • PRO15 Healthcare Resource Utilization Associated with NON-Dystrophic Myotonia: Results from a Delphi Panel

    Jun 1, 2021, 00:00

  • PDG10 Cost-Effectiveness Analysis of Gnrh Analogue ALONE Versus Combined Growth Hormone for Girls with Central Precocious Puberty

    Jun 1, 2021, 00:00

  • PCV58 Transcatheter Aortic Valve Implantation VS. Surgical Aortic Valve Replacement for Aortic Stenosis in Taiwan: A Population-Based Cohort Study

    Jun 1, 2021, 00:00

  • PUK5 Budget Impact Analysis of Vibegron for the Treatment of Overactive Bladder in the United States

    Jun 1, 2021, 00:00

  • PIN63 Choosing the Right COVID-19 Vaccine: A Multiple Stakeholder Multicriteria Decision Analysis For the Assessment of Available Vaccines in Latin America

    Jun 1, 2021, 00:00

  • Oncology Studies

    Jun 1, 2021, 00:00

  • Systemic Disorders/Conditions - Epidemiology Public Health

    Jun 1, 2021, 00:00

  • PMH15 Budget IMPACT Analysis of Lurasidone VS Other Atypical Antipsychotics in Patients with Schizophrenia in China

    Jun 1, 2021, 00:00

  • PMU29 Burden of COVID-19 Consequences: an Example of Post-viral Chronic Fatigue Syndrome

    Jun 1, 2021, 00:00

  • PNS93 Analysis of SF-6D Health State Utility Scores: Is Beta Regression Appropriate?

    Jun 1, 2021, 00:00

  • Sensory System Disorders - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PMH44 IMPACT of Clinical Pharmacist-Initiated Medication Information Services Among Psychiatric Patients

    Jun 1, 2021, 00:00

  • Rare Information Systems

    Jun 1, 2021, 00:00

  • Emerging Methods and Practices in Health Economics

    Jun 1, 2021, 00:00

  • PRO57 Is the B1 Variant of Tay Sachs Truly an Infantile Variant? Differences Unraveled Using the GM2 Disease Registry

    Jun 1, 2021, 00:00

  • PCN157 Characteristics and Treatment Patterns Among Patients Diagnosed with Metastatic Colorectal Cancer in the United States: A Healthcare Claims Database Analysis

    Jun 1, 2021, 00:00

  • PIN40 Risk Factors for Severe Outcomes in COVID-19 Confirmed or Suspected Beneficiaries Enrolled in Mississippi Medicaid

    Jun 1, 2021, 00:00

  • PIN29 Cost-Effectiveness of Nirsevimab Against Respiratory Syncytial VIRUS (RSV) Among US Infants Experiencing Their First RSV Season

    Jun 1, 2021, 00:00

  • PND18 BoNT-As for Adult Spasticity and Cervical Dystonia: Cost-Effectiveness Analysis and the Cost of Response in the United Kingdom

    Jun 1, 2021, 00:00

  • PND9 Exploring Serious Adverse Events Associated With Hospitalizations in a Long-term, Phase 3, Open-Label, Repeat-Dose, Safety Study of Diazepam Nasal Spray for Patients With Epilepsy

    Jun 1, 2021, 00:00

  • PSS15 Understanding Patients' Symptom Burden and Impact Across Retinal Disease Indications

    Jun 1, 2021, 00:00

  • Table of Contents

    Jun 1, 2021, 00:00

  • PNS110 Compliance with Epro Is High and Consistent across Age Groups with Patients Using Their Own Smartphones in FULLY Decentralized Clinical Trials

    Jun 1, 2021, 00:00

  • PMU10 A Descriptive Analysis of Costs and Healthcare Resource Use in Patients with Bronchiolitis Obliterans Syndrome (BOS) Following LUNG Transplantation

    Jun 1, 2021, 00:00

  • PNS68 Latin America HTA: Brazil and Argentina Report Card

    Jun 1, 2021, 00:00

  • Neurological Disorders - Economic Evaluation

    Jun 1, 2021, 00:00

  • PCN85 Real-World Treatment Patterns and Healthcare Costs Among Patients With Muscle-Invasive Urothelial Carcinoma Undergoing Radical Surgery in MarketScan Databases

    Jun 1, 2021, 00:00

  • Musculoskeletal Disorders - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PCN148 Community Oncologists' Experience and Perceptions of Cancer Survivorship

    Jun 1, 2021, 00:00

  • PNS76 The Growing Demand for HTA in Sub-Saharan Africa

    Jun 1, 2021, 00:00

  • PCV54 To Evaluate the Medication Persistence of Direct Oral Anticoagulants Among Patients with Atrial Fibrillation, Hypertension, Diabetes and Hyperlipidemia

    Jun 1, 2021, 00:00

  • SC2 Trends in Diagnostic Prevalence, Treatment Patterns, and Healthcare Resource Utilization of Pediatric Food Allergy Patients in the United States, 2008-2018

    Jun 1, 2021, 00:00

  • PSY23 Persistence and Adherence Among Patients with Psoriatic Arthritis Treated with Targeted Immune Modulators

    Jun 1, 2021, 00:00

  • PRO68 Patient-Reported Outcomes in Patients with Pemphigus Vulgaris Treated with Rituximab in the Phase 3 PEMPHIX Study

    Jun 1, 2021, 00:00

  • PMU63 Post-Lockdown Impact of the COVID-19 Pandemic on Patients Affected By Chronic Diseases in the United States

    Jun 1, 2021, 00:00

  • PRO62 Qualitative Interviews to Assess the Content Validity of a Novel Raynaud Diary in Patients with Systemic Sclerosis

    Jun 1, 2021, 00:00

  • ED2 Elements of Value for Gene Therapy: A Systematic Review

    Jun 1, 2021, 00:00

  • PMU69 Modifiable Lifestyle Risk Factors for Arterial Hypertension and Diabetes Mellitus in Beneficiaries of a Health PLAN in Brazil: A Retrospective Cohort

    Jun 1, 2021, 00:00

  • PCN91 Patient Responsible Out-of-Pocket Costs for Solitary Pulmonary Nodule Biopsy in Lung Cancer Patients

    Jun 1, 2021, 00:00

  • PBI19 Replicating Clinical Trial Exclusion Criteria in a Claims-Based Cohort of Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Initiating Intravenous Immunoglobulin (IVIG) Treatment

    Jun 1, 2021, 00:00

  • ST2 Exit Interviews with Caregivers and Clinicians Confirm Content Validity and Feasibility of Completing the Pediatric Respiratory Syncytial VIRUS (RSV) Electronic Severity and Outcome Rating System (PRESORS) for Pediatric RSV Clinical Stu ...

    Jun 1, 2021, 00:00

  • PND53 Predictive Models Leveraging Machine Learning and Real-World Data for Early Diagnosis: An Application in Amyotrophic Lateral Sclerosis

    Jun 1, 2021, 00:00

  • PCN118 Estimated Prevalence of Treated Locally Advanced or Metastatic Urothelial Carcinoma in Canada Using Simulation Modeling

    Jun 1, 2021, 00:00

  • PCN128 Incidence and Associated Risks of New Persistent and Continued Opioid Use in Patients with Cancer Receiving Radiotherapy

    Jun 1, 2021, 00:00

  • PCN187 Building Cancer Knowledge Graph for Clinical Decision Support Applications

    Jun 1, 2021, 00:00

  • Neurological Disorders - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • Mental Health - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PMH52 Use of a Natural Language Processing-Based Approach to Extract Suicide Ideation and Behavior from Clinical Notes to Support Depression Research

    Jun 1, 2021, 00:00

  • No Specific Disease - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • Cost-Effectiveness Analysis of Smoking Cessation Interventions in the United Kingdom Accounting for Major Neuropsychiatric Adverse Events

    Jun 1, 2021, 00:00

  • PNS15 Cost-Effectiveness Analysis of Pharmacogenetic Testing in Opioid Analgesia in Pediatric Population Undergoing Surgery

    Jun 1, 2021, 00:00

  • PNS116 Self-Rated Health (SRH) As a Predictor of Mortality: A Retrospective Cohort Study in a Private Health PLAN in Brazil

    Jun 1, 2021, 00:00

  • PCN140 Hospital Competition and Quality of Prostate Cancer Care

    Jun 1, 2021, 00:00

  • The Unfolding Method to Explore Health-Related Quality of Life Constructs in a Chinese General Population [Editor's Choice]

    Jun 1, 2021, 00:00

  • PCN87 Budget Impact Analysis (BIA) of Ruxolitinib for Treatment of Intermediate-2 or High Risk IPSS Myelofibrosis in the Brazilian Public Healthcare System (SUS)

    Jun 1, 2021, 00:00

  • PNS60 Impact of Pharmacist-led Medication Review on Hospital Readmission: A meta-analysis and Exploratory Evaluation of Hospitalization Definitions

    Jun 1, 2021, 00:00

  • PDG6 Budget Impact Analysis for Oliceridine in the Management of Moderate to Severe Acute Postoperative Pain

    Jun 1, 2021, 00:00

  • Mental Health - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • Cardiovascular Disorders - Epidemiology Public Health

    Jun 1, 2021, 00:00

  • PND23 Cost-effectiveness of Fremanezumab from a Societal Perspective in England

    Jun 1, 2021, 00:00

  • PSU8 Cost-Effectiveness Analysis of Perioperative Goal-Directed Fluid Therapy (PGDT) for High-Risk Hip Replacement Surgery from the Public Healthcare Perspective in Mexico

    Jun 1, 2021, 00:00

  • Systemic Disorders/Conditions - Economic Evaluation

    Jun 1, 2021, 00:00

  • PCN178 Cost-Effectiveness Analysis of Olaparib and Novel Hormonal Therapies in Metastatic Castration Resistant Prostate Cancer

    Jun 1, 2021, 00:00

  • PGI2 A Network Meta-Analysis to Compare Efficacy of Filgotinib with Other Treatments in Biologic-Experienced Patients with Moderately to Severely Active Ulcerative Colitis

    Jun 1, 2021, 00:00

  • PRS16 Cost-Effectiveness of Midazolam on Morphine Therapy for PAIN Relief in Critically ILL Ventilated Infants with Respiratory Distress Syndrome

    Jun 1, 2021, 00:00

  • PCN239 Development of the NOBLE (NOvartis Braf+ meLanoma patients obsErvational) Dataset: a Novel Approach to Creating a Longitudinal Melanoma Data Source by Harmonizing Multiple Electronic Health Record Databases

    Jun 1, 2021, 00:00

  • PNS90 Estimation of Markov Chain Transition Probabilities and Rates for Use As Inputs to Multistate Models

    Jun 1, 2021, 00:00

  • PDG9 Economic Impact of Cardiovascular Benefit of Once-Weekly Semaglutide in Type 2 Diabetes Patients with High Cardiovascular Risk in China

    Jun 1, 2021, 00:00

  • Cancer - Conceptual Papers (CP)

    Jun 1, 2021, 00:00

  • PDB3 Trends in Prices of Insulin Marketed in the U.S.

    Jun 1, 2021, 00:00

  • ST4 Psychometric Evaluation of the Pediatric RSV Severity and Outcomes Rating System Version 6 (PRESORSV6), Caregiver Observer-Reported [ObsRO] and Clinician-Reported [ClinRO] Questionnaires in Children Aged 1 to 36 Months Hospitalized with ...

    Jun 1, 2021, 00:00

  • PCV21 Cost-Effectiveness of Atorvastatin Versus Simvastatin in Prevention of Cardiovascular Events from a Thailand Societal Perspective

    Jun 1, 2021, 00:00

  • PCN145 Clinical Pathways As Input to HTA Processes: Lessons from the Experience of a Referral Cancer Centre

    Jun 1, 2021, 00:00

  • PCN225 Patient-Reported Outcomes Associated with Cancer Screening: A Systematic Review

    Jun 1, 2021, 00:00

  • PCN206 Evaluating Patient Experiences in Follicular Lymphoma (FL) through Social Media Listening (SML) Research from Five Countries in North America and Europe

    Jun 1, 2021, 00:00

  • PIN82 Real-World Utilization of Remdesivir in 2020: A Retrospective Cohort Study

    Jun 1, 2021, 00:00

  • PMH46 Treatment Patterns With Aripiprazole Lauroxil Versus Other Atypical Long-Acting Injectable Antipsychotics in Patients With Schizophrenia: A Retrospective Electronic Health Records Database Study

    Jun 1, 2021, 00:00

  • PIN39 Clinical Burden and Costs Associated with Potential Pneumococcal Disease Hospitalizations Among Older Adults in Brazil

    Jun 1, 2021, 00:00

  • PRO72 Common and Serious Comorbidities Among Adults with Wilson Disease

    Jun 1, 2021, 00:00

  • Individual's Health - Health Policy Regulatory

    Jun 1, 2021, 00:00

  • PRO6 Clinical and Ambulatory Characteristics in Adult Patients with Spinal Muscular Atrophy: A Natural History Multi-Country Chart Review Study

    Jun 1, 2021, 00:00

  • PCN13 Quality-of-Life (QOL) Results from the Phase 3 Rainbow-ASIA Study of Ramucirumab PLUS paclitaxel (RAM/PTX) Versus Placebo PLUS paclitaxel (PBO/PTX) in Patients with Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (AGC)

    Jun 1, 2021, 00:00

  • PCN177 Trends in Canadian Oncology Health Technology Assessment

    Jun 1, 2021, 00:00

  • PCN20 Efficacy and Safety of Selinexor for Patients with Relapsed and Refractory Multiple Myeloma: A Meta-Analysis

    Jun 1, 2021, 00:00

  • PIH4 Cost-Effectiveness of Rapid Screening in Antenatal Care in Bugesera District, Rwanda

    Jun 1, 2021, 00:00

  • Cancer - Health Policy Regulatory

    Jun 1, 2021, 00:00

  • Biologics/Biosimilars/Regenerative Medicine - Epidemiology Public Health

    Jun 1, 2021, 00:00

  • PNS73 The "NICEness" of NICE: A Time-Trend Analysis

    Jun 1, 2021, 00:00

  • PBI11 Economic Impact of Utilizing Eptacog Beta for the on-Demand Treatment of Bleeding Events Among Hemophilia Patients with Inhibitors

    Jun 1, 2021, 00:00

  • Drugs Public Health

    Jun 1, 2021, 00:00

  • PIH37 A Comparison of Self-reported and Proxy-reported Health Utilities in Children: A Systematic Review and Meta-Analysis

    Jun 1, 2021, 00:00

  • PNS47 Analysis of Pharmacies Included in the Reimbursement Program in Ukraine

    Jun 1, 2021, 00:00

  • PNS51 Global Survey of Genetic Testing Reimbursement Policies

    Jun 1, 2021, 00:00

  • PSS2 Development of Glaucoma Following Endothelial Keratoplasty Among Patients with Fuchs' Endothelial Dystrophy: Real-World Data Analysis of a Commercially Insured US Population (2014-2019)

    Jun 1, 2021, 00:00

  • PCV45 The Healthcare Effects of the Ochsner Hypertension Digital Medicine Program

    Jun 1, 2021, 00:00

  • HP4 Dose Medicaid Expansion Provide Affordability of Helathcare Service for Asthma Population

    Jun 1, 2021, 00:00

  • PCN228 Chemobrain: NOT Such a Foggy Concept in Reality

    Jun 1, 2021, 00:00

  • PDG29 Specialty Pharmacy Turnaround Time: Impediments, Facilitators, and Best Practices

    Jun 1, 2021, 00:00

  • PIN34 COVID-19 Related Knowledge, Attitude and Practices in a Southeastern City in Nigeria: A Cross-Sectional Survey

    Jun 1, 2021, 00:00

  • PIN60 Effect of Community Based Intervention on Isoniazid Preventive Therapy Uptake Among People Living with HIV in FAR Western Province of Nepal: A Cluster Randomized Controlled Trial

    Jun 1, 2021, 00:00

  • HT4 Patient-Relevance of Endpoints Other Than Overall Survival (Non-OS Endpoints) in Oncology Health Technology Assessments by the Federal Joint Committee (G-BA) in Germany

    Jun 1, 2021, 00:00

  • PCV44 Real-World Assessment of the Use of Anti-platelet Therapy for Recurrent Stroke Prevention in US Patients without Atrial Fibrillation with Recent Ischemic Stroke or Transient Ischemic Attack

    Jun 1, 2021, 00:00

  • Methods Used to Identify, Test, and Assess Impact on Preferences of Bolt-Ons: A Systematic Review [Editor's Choice]

    Jun 1, 2021, 00:00

  • PGI27 Applying Machine Learning to Large Databases to Predict Nonresponse to Conventional Treatment in Patients with Ulcerative Colitis

    Jun 1, 2021, 00:00

  • PNS96 Healthcare and Policy Design: Comparison of Clinical Guidelines Guidance and Machine Learning

    Jun 1, 2021, 00:00

  • PMU6 Cost Analysis Of The First Patient-Centered Medical Home (PCMH) in Singapore: Perspectives From Healthcare Providers, Patients, And Society As A Whole

    Jun 1, 2021, 00:00

  • PCN203 Valuing Hope with Cancer Treatments Independent of Survival Gains

    Jun 1, 2021, 00:00

  • PSS14 Qualitative Exploration of Patient Experiences of Visual Function Impairments and Health-Related Quality of Life Impacts Associated with RLBP1 Retinitis Pigmentosa in a Sample of Canadian Patients

    Jun 1, 2021, 00:00

  • PCN72 An EARLY Cost-Effectiveness Analysis of Xevinapant in Combination with Chemo-Radiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck in United States.

    Jun 1, 2021, 00:00

  • PND16 Socioeconomic Value of Ocrelizumab in the Treatment of Patients with Primary Progressive Multiple Sclerosis

    Jun 1, 2021, 00:00

  • PMS8 National Burden of Achondroplasia in Adults and Children: An Analysis of the National Inpatient Sample

    Jun 1, 2021, 00:00

  • PRO50 A Discrete Choice Experiment to Derive Health State Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency in France

    Jun 1, 2021, 00:00

  • PMD8 Cost-Effectiveness Model of Sutureless Aortic Valve in Aortic Valve Replacement - an Adaptation to the Brazilian Public Healthcare Setting

    Jun 1, 2021, 00:00

  • EM2 Economic IMPACT of Compassionate Use of Medicines

    Jun 1, 2021, 00:00

  • PCN248 Productivity Costs Associated with Disease Recurrence Among Surgically-Treated Patients with Triple-Negative Breast Cancer

    Jun 1, 2021, 00:00

  • Rare Statistical Research

    Jun 1, 2021, 00:00

  • Urinary/Kidney Disorders - Epidemiology Public Health

    Jun 1, 2021, 00:00

  • PNS117 Correlation between Self-Reported and Clinical Measures of Weight, Height and Body MASS INDEX in Adults Members of a Private Health Insurance Company in Colombia, 2019

    Jun 1, 2021, 00:00

  • PCN98 Analysis of Societal Costs Due to Work Productivity Loss and Activity Impairment from the Monaleesa-7 Trial of Ribociclib + Endocrine Therapy (ET) in Premenopausal Women with HR+/HER2− Advanced Breast Cancer (ABC) in the US

    Jun 1, 2021, 00:00

  • PSY7 Increased Length and Cost of Hospital Stay in Inpatients with Iron Deficiency Anemia Experiencing Moderate-Severe Hypophosphatemia after Administration of Ferric Carboxymaltose

    Jun 1, 2021, 00:00

  • PDG35 Using Machine Learning to Classify Patients on Opioid Use

    Jun 1, 2021, 00:00

  • PIN13 Cost-Minimization Analysis of Introducing Hexaxim® into Korean National Immunization Program

    Jun 1, 2021, 00:00

  • Caregiver Considerations in Health Economics

    Jun 1, 2021, 00:00

  • PIN44 COVID-19 Knowledge, and Mental Health IMPACT Assessment in Haiti

    Jun 1, 2021, 00:00

  • Hospital and Clinical Practice Studies

    Jun 1, 2021, 00:00

  • PIN18 The Potential Cost-Effectiveness of Using Community Pharmacies to Increase Human Papillomavirus Vaccination Rates in the United States

    Jun 1, 2021, 00:00

  • PSS6 Identification of Healthcare Expenditures Associated with Frequent Exercise Status Among United States Older Adults with Self-Reported PAIN

    Jun 1, 2021, 00:00

  • Rare Orphan Diseases - Conceptual Papers (CP)

    Jun 1, 2021, 00:00

  • PNS81 Is Telehealth in Primary Care Cost-Effective? a Systematic Review

    Jun 1, 2021, 00:00

  • PRO77 Preliminary Characterization of Eculizumab Treatment Patterns, Preceding Disease Triggers and Supportive Therapies in Atypical Hemolytic Uremic Syndrome: A US Claims Database Analysis

    Jun 1, 2021, 00:00

  • Cardiovascular Disorders - Health Policy Regulatory

    Jun 1, 2021, 00:00

  • PCN35 Systematic and Structured Reviews of the Disease Burden in Patients with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (DMMR) Colorectal Cancer (CRC)

    Jun 1, 2021, 00:00

  • Respiratory-Related Disorders - Economic Evaluation

    Jun 1, 2021, 00:00

  • PRO37 The Epidemiology, Methods of Diagnosis, and Clinical Management of Patients with Arginase 1 Deficiency (ARG1-D): A Systematic Review

    Jun 1, 2021, 00:00

  • PNS44 Linking Personal Health to the Living Environment and Poverty: A Case Study of Schenectady, NY

    Jun 1, 2021, 00:00

  • PMS6 Association between Knee Symptoms, Change in Knee Symptoms over 6–9 YEARS and SF-6D Health State Utility Among Middle-Aged Australians

    Jun 1, 2021, 00:00

  • ED3 Societal Burden of Dementia-Related Psychosis in the US: A Cost of Illness Analysis

    Jun 1, 2021, 00:00

  • PCN114 Investigating Secular Trends in the Survival of Melanoma Patients in England

    Jun 1, 2021, 00:00

  • Measuring the Value Healthy Individuals Place on Generous Insurance Coverage of Severe Diseases: A Stated Preference Survey of Adults Diagnosed With and Without Lung Cancer

    Jun 1, 2021, 00:00

  • Individual's Health - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • PCV57 Persistence to Warfarin Among Patients with Atrial Fibrillation and Comorbid Hypertension, Diabetes and Hyperlipidemia

    Jun 1, 2021, 00:00

  • PND32 Out-of-Pocket Payments and Healthcare Resource Utilization in Patients with Episodic and Chronic Migraine in Moscow, Russia

    Jun 1, 2021, 00:00

  • PNS62 Project Orbis/Access Consortium - Are Quicker Regulatory Approvals Leading to Faster Reimbursement?

    Jun 1, 2021, 00:00

  • PMD9 Cost-Effectiveness of an Antibacterial Envelope for Cardiac Electronic Implantable Devices in High-Risk Patients in the Public Sector in Mexico

    Jun 1, 2021, 00:00

  • PSU13 Effects of Certain Ingredients in Iron Supplements or Iron-Fortified Foods on Diarrhea in Infants Younger THAN 1 Year of Age: A Systematic Review and Meta-Analysis

    Jun 1, 2021, 00:00

  • PND43 Predictors of 30-Day Readmission and Hospitalization Costs of Patients with Hepatic Encephalopathy in the US from 2010 to 2014

    Jun 1, 2021, 00:00

  • Respiratory-Related Disorders - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • PMU14 The IMPACT of Social and NOVEL Elements on Cost-Effectiveness Analysis: Two Case Studies

    Jun 1, 2021, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PMH50 IMPACT of Clinical Pharmacist Intervention in Patients with Bipolar Affective Disorder in South India

    Jun 1, 2021, 00:00

  • EC3 Economic Burden of Cardiovascular Events in Patients with Chronic Lymphocytic Leukemia Treated with Novel Agents

    Jun 1, 2021, 00:00

  • PCN68 Brigatinib Compared with Crizotinib and Alectinib in Patients with ALK-Positive Non-Small Cell Lung Cancer (NSCLC) with Brain Metastases at Diagnosis: A Cost-Effectiveness Analysis from the Perspective of the Brazilian Private Health ...

    Jun 1, 2021, 00:00

  • PIN58 The U.S. International Trade of Medical Products in the COVID-19 Era

    Jun 1, 2021, 00:00

  • ML2 Supervised Machine Learning Predicts Mortality in COVID-19 Patients Using Electronic Health Records

    Jun 1, 2021, 00:00

  • PNS37 Positive Decisions by Minister of Health on Reimbursement of Innovative Drugs in Poland Lack Content-Related Justifications - an Analysis of Quality of Justifications of Decisions to Include Drugs in Public Funding

    Jun 1, 2021, 00:00

  • PSY4 Budget Impact of Baricitinib for Moderate-to-Severe Atopic Dermatitis Patients with an Inadequate Response to Topical Treatments

    Jun 1, 2021, 00:00

  • Impact of COVID-19 on Health Systems, Treatment, and Value

    Jun 1, 2021, 00:00

  • Drugs Regulatory

    Jun 1, 2021, 00:00

  • Multiple Diseases - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • PCN103 Cost-Effectiveness of Palbociclib in Combination with Letrozole Versus Letrozole ALONE for Patients with Advanced or Metastatic Breast Cancer HR+ / HER2- in the Brazilian Public Healthcare System

    Jun 1, 2021, 00:00

  • PSY2 Impact of Mepolizumab on Health-Related Quality of Life in Patients With Hypereosinophilic Syndrome

    Jun 1, 2021, 00:00

  • PIN65 Systematic Literature Review on Modelling of Infectious Diseases in Elderly

    Jun 1, 2021, 00:00

  • PND28 Budget Impact Analysis of the Incorporation of Mechanical Thrombectomy with Stent Retrievers after Thrombolysis in Ischemic-Stroke with Large Vessel Occlusion in Obras Sociales and Empresas De Medicina Prepaga in Argentina

    Jun 1, 2021, 00:00

  • PCN121 Estimating Prevalence in Oncology: The Development of a More Accurate Prevalence Formula

    Jun 1, 2021, 00:00

  • PMS5 Gout Management after Pegloticase in US Clinical Practice; Observations from Trio Health and the American Rheumatology Network

    Jun 1, 2021, 00:00

  • PNS12 Can a Reusable Surgical Face Mask Bring Health Economic and Ecological Benefit to a Health System upon the Outbreak of an Emerging Pathogen?

    Jun 1, 2021, 00:00

  • RW2 Real-World Evidence of Option Value in Metastatic Melanoma

    Jun 1, 2021, 00:00

  • PCN144 Real-World Treatment Patterns Among Patients with Mycosis Fungoides or Sezary Syndrome in the United States

    Jun 1, 2021, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • PCN45 Analysis of Societal Costs Due to Work Productivity Loss and Activity Impairment from the Monaleesa-7 Trial of Ribociclib + Endocrine Therapy (ET) in Premenopausal Women with HR+/HER2– Advanced Breast Cancer (ABC) in Brazil

    Jun 1, 2021, 00:00

  • PCN247 Association between Health-Related Quality of Life and Productivity Loss Among Working-Age Women with Breast Cancer in the United States

    Jun 1, 2021, 00:00

  • PCN158 Potential Drug-Drug Interactions to Novel Anti-Androgen Therapies Among Non-Metastatic Castration-Resistant Prostate Cancer Patients

    Jun 1, 2021, 00:00

  • PCV19 Cost-Effectiveness Analysis of the Pipeline Embolization Device (PED) Compared with Stent Assisted Coiling and Neurosurgical Clipping for Treatment of Intracranial Aneurysms in Colombia

    Jun 1, 2021, 00:00

  • PDG38 Association between Satisfaction with Quality of Care and ANTI-Dementia Medication Adherence Among Elderly Adults with Alzheimer's Disease and Related Dementias

    Jun 1, 2021, 00:00

  • PMU39 Effects of the Medicare PART D Comprehensive Medication Review on Racial and Ethnic Disparities in Medication Utilization

    Jun 1, 2021, 00:00

  • Reimbursement and Access Policy Studies

    Jun 1, 2021, 00:00

  • PRO51 Caring for an Individual with Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: Analysis of Reported Time for Practical and Emotional Care and Paid/Unpaid Help

    Jun 1, 2021, 00:00

  • PNS50 Defining and Applying the Health Value Score to Evaluate 17 Nonprofit Hospitals in the State of Minas Gerais, Brazil

    Jun 1, 2021, 00:00

  • PUK4 General Practitioner Utilization and Costs of Chronic Kidney Disease According to the 2012 KDIGO CKD Classification: A Report from the DISCOVER CKD Retrospective Cohort

    Jun 1, 2021, 00:00

  • MT4 Safety Warnings about Power Morcellation in Hysterectomy: A Simulation of National Impact

    Jun 1, 2021, 00:00

  • PNS55 Perceived Discrimination and Cost-Related Non-Utilization of Healthcare Services: A Systematic Examination of Explanatory Factors

    Jun 1, 2021, 00:00

  • PNS91 Blue Cross Blue Shield of Louisiana Approach Using Natural Language Processing and Machine Learning to Predict the Risk of Hospitalizations (ROH) for Medicaid Patients

    Jun 1, 2021, 00:00

  • PIH17 Prescription Medication Use in a Representative US Sample of Pregnant Women

    Jun 1, 2021, 00:00

  • PIN8 Application of Innovative Pricing in Response to the COVID-19 Pandemic

    Jun 1, 2021, 00:00

  • PCN191 Cost Associated with Implementation of CAR T-Cell Therapy for the Management of Hematologic Cancers in Canada.

    Jun 1, 2021, 00:00

  • PIN27 Cost-utility Analysis Focused on Nosocomial Pneumonia Antimicrobial Therapy - Is Ceftolozane/Tazobactam an Option to Fight Antimicrobial Resistance Sustaining Public Health System Affordability in Brazil?

    Jun 1, 2021, 00:00

  • PBI10 Economic Impact of Originator-to-Biosimilar Non-Medical Switching on Health Care Resource Utilization in Rheumatic Patients in Quebec, Canada

    Jun 1, 2021, 00:00

  • PCN132 Immune-Related Adverse Events (IRAES) in Melanoma Patients Treated with Programmed Cell Death-1 (PD-1) Inhibitors: An Analysis Using the DATA from FDA Adverse Event Reporting System (FAERS)

    Jun 1, 2021, 00:00

  • PND27 Cost-of-Illness for Adults with Generalized Myasthenia Gravis in the US

    Jun 1, 2021, 00:00

  • PMU61 State of BYOD: Lessons in Acceptability and Compliance from 35 Trials

    Jun 1, 2021, 00:00

  • PCN130 Dose-Dependent Relation between Metformin and the Risk of Hormone Receptor-Positive, HER2-Negative (HR+/HER2-) Breast Cancer Among Postmenopausal Women with Type-2 Diabetes

    Jun 1, 2021, 00:00

  • PND24 Cost-Utility of Mechanical Thrombectomy after Thrombolysis in Ischemic-Stroke Due to Large Vessel Oclussion in Programa De Atencion medica Integral Pami in Argentina

    Jun 1, 2021, 00:00

  • PMS17 Patient and Provider Factors Associated with Aseptic Loosening Following Cemented Primary Knee Total Arthroplasty

    Jun 1, 2021, 00:00

  • PDB23 Investigating Internists’ Endocrinologists’ and Paediatricians’ Attitudes in Regards to the VALUE of Innovative Diabetes Mellitus Self-Monitoring Technologies in Greece

    Jun 1, 2021, 00:00

  • PRO9 ADV7103 Treatment Adherence in Patients with Distal Renal Tubular Acidosis (DRTA)

    Jun 1, 2021, 00:00

  • PRO52 A qualitative study on the impact of caring for an individual with aromatic l-amino acid decarboxylase deficiency (AADCd)

    Jun 1, 2021, 00:00

  • PRO32 Extended Half-Life (EHL) Recombinant Factor VIII (RFVIII) for the Treatment of Hemophilia a in Italy: Cost of Treatment Comparison

    Jun 1, 2021, 00:00

  • PMU15 A Budget Impact Analysis of Universal Hepatitis C Virus (HCV) Testing for Patients with Substance Use Disorders

    Jun 1, 2021, 00:00

  • PNS100 Comparison of Test-Rest Reliability of Cardinal and Ordinal Preference Elicitation Methods

    Jun 1, 2021, 00:00

  • PMH7 Assessment of Patient out-of-Pocket Costs for Antipsychotic Treatments Among Medicaid Beneficiaries with Schizophrenia

    Jun 1, 2021, 00:00

  • Artificial Intelligence Method Studies

    Jun 1, 2021, 00:00

  • PCN54 Comparison of Cost Versus Reimbursement for Definitive Radiotherapy for Locally Advanced Cervical Cancer Using Time-Driven Activity-Based Costing

    Jun 1, 2021, 00:00

  • PRS21 Quantifying the years of life lost due to COVID-19 in Colombia: preliminary estimates

    Jun 1, 2021, 00:00

  • PRO75 Demographics and Relapse Profile Correlates with Treatment Change in Neuromyelitis Optica Spectrum Disorder (NMOSD) Patients: Analysis of the Circles Study

    Jun 1, 2021, 00:00

  • PMU56 Health Economic Evaluation Alongside Stepped Wedge Trials: A Methodological Systematic Review and Recommendations of Appropriate Modelling Approaches

    Jun 1, 2021, 00:00

  • PIN42 Molecular Testing Dynamics Is Reactive to COVID-19 Inciden Observations from the Colombian Experience

    Jun 1, 2021, 00:00

  • Medical Devices - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • Cardiovascular Disorders - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • PNS14 Direct Medical Costs Related to COVID-19 in Colombia

    Jun 1, 2021, 00:00

  • PDB46 A Best-Worst Scaling Preference Study: The Mealtime Insulin Experience for People with Diabetes in US and UK

    Jun 1, 2021, 00:00

  • PIN25 A Systematic Review of the Use of Productivity Loss/GAIN in Cost-Effectiveness Analyses for Vaccines

    Jun 1, 2021, 00:00

  • PIH16 Clinical Characteristics, Comorbid Conditions, Treatment Patterns, and Healthcare Resource Utilization of Adults, Adolescents, and Children with Peanut Allergy in the United States

    Jun 1, 2021, 00:00

  • PUK21 PatientsÂ’ Preferences for a Wearable Digital Health Technology to Support Self-Management of Chronic Kidney Disease

    Jun 1, 2021, 00:00

  • PCN234 Challenges in Estimating Sample Size for Retrospective Real-World Research

    Jun 1, 2021, 00:00

  • PCN131 Epidemiological Profile of Melanoma in the Brazilian Public Healthcare System

    Jun 1, 2021, 00:00

  • PIN4 Comparative Effectiveness in Medication Adherence between VIDEO-Observed Therapy and Directly-Observed Therapy in Tuberculosis-Infected Patients: A Systematic Review and Meta-Analysis

    Jun 1, 2021, 00:00

  • PDG7 Cost Effectiveness Analysis of Oliceridine Compared with Morphine in the Management of Postoperative Moderate to Severe ACUTE PAIN in a High Risk Population

    Jun 1, 2021, 00:00

  • PMU12 Cost-Benefit Analysis of Sodium Glucose Cotransporter-2 Inhibitor Use for Patients 65 Years with Type 2 Diabetes and Heart Failure with Reduced Ejection Fraction

    Jun 1, 2021, 00:00

  • PRO67 The Use of Vignettes to Derive Health Utilities for Spinal Muscular Atrophy Type I (SMA-I)

    Jun 1, 2021, 00:00

  • ML3 LASSO (Least Absolute Shrinkage and Selection Operator) and XGBoost (eXtreme Gradient Boosting) Models for Predicting Depression-Related Work Impairment in US Working Adults

    Jun 1, 2021, 00:00

  • PCN175 Pan-Cancer Early Detection Tests: Considering Potential Benefits and Harms

    Jun 1, 2021, 00:00

  • PRS6 A Model for Determining the Budget Impact of Introducing a New Single-Inhaler Triple Combination Therapy for Managing Moderate to Very Severe COPD in the United States

    Jun 1, 2021, 00:00

  • PRO3 Systematic Literature Review (SLR) of Evidence on Clinical, Humanistic, and Economic Burden for Patients Who Have Undergone the Fontan Procedure

    Jun 1, 2021, 00:00

  • PRO63 The Burden of X-Linked Retinitis Pigmentosa on Patients and Society: A Comprehensive Review

    Jun 1, 2021, 00:00

  • PCN164 Impact of Treatment and Patient Attributes on Oncologists Decision-Making in First-line Chronic Lymphocytic Leukemia (CLL) in the United States (US)

    Jun 1, 2021, 00:00

  • PCN24 Evaluating the Surrogacy of Objective Response Rate for Overall Survival in Oncology Clinical Trials: A Methodologic Review

    Jun 1, 2021, 00:00

  • PCN64 Cost Per Objective Response With Dabrafenib+Trametinib As The First Line Of Treatment In Patients With Unresectable Or Metastatic Melanoma With BRAF V600 Mutation In Colombia

    Jun 1, 2021, 00:00

  • PRS35 Real-World Clinical Characteristics of 112 Patients with Idiopathic Pulmonary Fibrosis: Update from the Trio Health IPF Registry

    Jun 1, 2021, 00:00

  • PMS4 Gout Management with Pegloticase in US Clinical Care; Observations from Trio Health and The American Rheumatology Network

    Jun 1, 2021, 00:00

  • PIN3 Impact of Antimicrobial Stewardship Interventions on Compliance with Surgical Antibiotic Prophylaxis: A Systematic Review

    Jun 1, 2021, 00:00

  • PMH41 Health-Related Quality of Life of Type-2 Diabetic Patients with Diagnosed Depression, Undiagnosed Depression and No Depression in the United States: Medical Expenditure Panel Survey, 2016-2018

    Jun 1, 2021, 00:00

  • PNS13 Comparative Network Efficiency Analysis of Brazil Response to COVID-19 at State Level

    Jun 1, 2021, 00:00

  • Multiple Diseases - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • Mixed Diseases and Condition Studies

    Jun 1, 2021, 00:00

  • PIN20 Predicting the IMPACT of Vaccination Strategies in the COVID-19 Pandemic Using a Susceptible-Exposed-Infectious-Removed (SEIR) MODEL

    Jun 1, 2021, 00:00

  • Drugs Generics - Conceptual Papers (CP)

    Jun 1, 2021, 00:00

  • PAM2 30 Day Readmissions of Patients with a Malnutrition Diagnosis: Exploration of the US Hospital Population

    Jun 1, 2021, 00:00

  • Gastrointestinal Disorders - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • PRO70 Examining the Relationship between Treatment Regimen and Clinical and Employment Outcomes: An Analysis of Severe Hemophilia in the US, Using the CHESS US+ Database

    Jun 1, 2021, 00:00

  • Neurological Disorders - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PRS5 Direct Medical and Mortality Related Costs Among COPD Patients in the United States, 2017-2018

    Jun 1, 2021, 00:00

  • PRO46 Measuring carer utility in rare paediatric disease: a mixed Methods case study in aromatic l-amino acid decarboxylase deficiency (AADCd)

    Jun 1, 2021, 00:00

  • Cancer - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • PSY17 Time Trade-Off Utilities for Hereditary Angioedema Health States

    Jun 1, 2021, 00:00

  • PIN24 Cost-Effectiveness of Syringe Service Programs and Medications for Opioid Use Disorder in Reducing the Risk of Hepatitis C Among Opioid Injection Drug Users in the United States

    Jun 1, 2021, 00:00

  • Infectious Diseases - Epidemiology Public Health

    Jun 1, 2021, 00:00

  • PCN104 The Appropriate Health Economic Modeling Approach in Cancer Screening Tests

    Jun 1, 2021, 00:00

  • PCN189 Application of Augmented Intelligence (AI) in Oncology: A Physician Perspective

    Jun 1, 2021, 00:00

  • PIN37 Influenza and RSV-Attributable Cardiorespiratory Hospitalizations in U.S. Long-Term Care Facilities

    Jun 1, 2021, 00:00

  • The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set

    Jun 1, 2021, 00:00

  • Are Drugs Priced in Accordance With Value? A Comparison of Value-Based and Net Prices Using Institute for Clinical and Economic Review Reports [Editor's Choice]

    Jun 1, 2021, 00:00

  • PIN68 Estimating Effects in Observational Real-World Data, From Target Trials to Targeted Learning: Example of Treating COVID-Hospitalized Patients

    Jun 1, 2021, 00:00

  • PNS82 The Methods for Incorporating Carer HRQoL Should be More Clearly Defined By NICE

    Jun 1, 2021, 00:00

  • PIH38 Performance of Proxy-reported EQ-5D Youth Version 5-Level (EQ-5D-Y-5L) in Comparison with Three-Level (EQ-5D-Y-3L) in Chinese Patients with Adolescent Idiopathic Scoliosis

    Jun 1, 2021, 00:00

  • PNS92 A Targeted Review of Indirect Treatment Comparison Synthesis Methods That Do Not Rely on the Proportional Hazard Assumption

    Jun 1, 2021, 00:00

  • Surgery - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • PCN235 Health-Related Quality of Life of HPV-Related Cancer Patients in the United States: 2010-2018

    Jun 1, 2021, 00:00
  • «
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47 (current)
  • 48
  • 49
  • 50
  • »